相关实验视频

Updated: Jan 9, 2026

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

在最近的DLBCL注册试验中对老年患者的纳入,特征和报告:系统性审查

Nina Rosa Neuendorff¹, Kelly Pugh², Ronit Juthani³

¹Universitätsklinik Marien Hospital Herne, Herne, Germany.

|December 6, 2025

概括

在扩散性大B细胞淋巴瘤 (DLBCL) 临床试验中报告老年人结局需要改进. 对老年患者的疗效,生活质量和毒性基本数据往往缺失,阻碍了治疗相关性评估.

科学领域:

在瘤学瘤学.
临床试验分析
老年医学老年医学

背景情况:

扩散性大B细胞淋巴瘤 (DLBCL) 的发病率随着年龄的增长而上升,因此需要针对老年人的具体数据.
脆弱的老年人群需要在临床试验中进行子组分析,以验证新疗法的有效性.
像FDA和EMA这样的监管机构批准DLBCL治疗,这强调了对年龄特定数据的需求.

研究的目的:

评估DLBCL注册试验中老年成人子组 (≥65岁) 的报告完整性.
评估老年患者的有效性,基线特征,生活质量和毒性数据的可用性.
识别子组报告中的差距,以告知未来的临床试验设计和数据收集.

主要方法:

2017-2023年期间FDA和EMA批准的DLBCL注册试验的系统审查.
从ClinicalTrials.gov,研究协议以及通过Covidence.com的初级/二级出版物提取数据.
对老年人亚组数据完整性的评估,根据预定义的终点和结果标准进行评估.

主要成果:

在老年人中,83%的初级疗效终点被完全报告;二级终点被显著报告不足 (38%完整).
老年人的基线特征,与健康相关的生活质量和毒性结果在试验出版物中基本上缺席.
在12个已批准的DLBCL症状中,报告情况各不相同,老年人群的综合数据存在重大差距.

结论:

在DLBCL临床试验中报告老年人亚组数据存在重大缺陷,特别是对于二次终点.
改善报告标准对于了解日益增长的老年DLBCL患者群体的治疗疗效和安全至关重要.
未来的DLBCL试验必须优先考虑对老年人的详细子组分析和报告,以确保治疗的相关性和安全性.

更多相关视频

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

相关概念视频

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...